{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T18:19:54Z","timestamp":1792433994051,"version":"4.5.0"},"reference-count":59,"publisher":"American Society of Hematology","issue":"5","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Splenic marginal zone B-cell lymphoma (SMZL) is a heterogeneous clinico-biological entity. The clinical course is variable, multiple genes are mutated with no unifying mechanism, and essential regulatory pathways and surrounding microenvironments are diverse. We sought to clarify the heterogeneity of SMZL by resolving different subgroups and their underlying genomic abnormalities, pathway signatures, and microenvironment compositions to uncover biomarkers and therapeutic vulnerabilities. We studied 303 SMZL spleen samples collected through the IELSG46 multicenter international study (NCT02945319) by using a multiplatform approach. We carried out genetic and phenotypic analyses, defined self-organized signatures, validated the findings in independent primary tumor metadata and determined correlations with outcome data. We identified 2 prominent genetic clusters in SMZL, termed NNK (58% of cases, harboring NF-\u03baB, NOTCH, and KLF2 modules) and DMT (32% of cases, with DNA-damage response, MAPK, and TLR modules). Genetic aberrations in multiple genes as well as cytogenetic and immunogenetic features distinguished NNK- from DMT-SMZLs. These genetic clusters not only have distinct underpinning biology, as judged by differences in gene-expression signatures, but also different outcomes, with inferior survival in NNK-SMZLs. Digital cytometry and in situ profiling segregated 2 basic types of SMZL immune microenvironments termed immune-suppressive SMZL (50% of cases, associated with inflammatory cells and immune checkpoint activation) and immune-silent SMZL (50% of cases, associated with an immune-excluded phenotype) with distinct mutational and clinical connotations. In summary, we propose a nosology of SMZL that can implement its classification and also aid in the development of rationally targeted treatments.<\/jats:p>","DOI":"10.1182\/blood.2021012386","type":"journal-article","created":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T17:54:43Z","timestamp":1634752483000},"page":"732-747","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":94,"title":["Genetic and phenotypic attributes of splenic marginal zone lymphoma"],"prefix":"10.1182","volume":"139","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2488-3867","authenticated-orcid":false,"given":"Ferdinando","family":"Bonfiglio","sequence":"first","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Bruscaggin","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Guidetti","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodovico","family":"Terzi di Bergamo","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8807-6146","authenticated-orcid":false,"given":"Martin","family":"Faderl","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Spina","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adalgisa","family":"Condoluci","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"},{"name":"Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisella","family":"Bonomini","sequence":"additional","affiliation":[{"name":"International Extranodal Lymphoma Study Group, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Forestieri","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Koch","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Piffaretti","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Pini","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5277-9835","authenticated-orcid":false,"given":"Maria Cristina","family":"Pirosa","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4400-1526","authenticated-orcid":false,"given":"Micol Giulia","family":"Cittone","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"},{"name":"Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3123-6203","authenticated-orcid":false,"given":"Alberto","family":"Arribas","sequence":"additional","affiliation":[{"name":"Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-3646","authenticated-orcid":false,"given":"Marco","family":"Lucioni","sequence":"additional","affiliation":[{"name":"Unit of Anatomic Pathology, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo and Universit\u00e0 degli Studi di Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Ghilardi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9504-991X","authenticated-orcid":false,"given":"Luca","family":"Arcaini","sequence":"additional","affiliation":[{"name":"Division of Hematology, Fondazione IRCCS Policlinico San Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3471-2535","authenticated-orcid":false,"given":"Maria Joao","family":"Baptista","sequence":"additional","affiliation":[{"name":"Lymphoid Neoplasms Group, Josep Carreras Leukaemia Research Institute, Badalona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Bastidas","sequence":"additional","affiliation":[{"name":"Division of Hematology, Hospital Cl\u00ednic i Provincial de Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7192-2385","authenticated-orcid":false,"given":"Silvia","family":"Bea","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi Sunyer (IDIBAPS),"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC) 28029, Madrid, Spain;"},{"name":"Pathology Department, Hospital Cl\u00ednic, Barcelona University, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Boldorini","sequence":"additional","affiliation":[{"name":"Division of Pathology, University of Eastern Piedmont, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Broccoli","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Ser\u00e0gnoli, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0850-3326","authenticated-orcid":false,"given":"Marco Matteo","family":"Buehler","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6010-0976","authenticated-orcid":false,"given":"Vincenzo","family":"Canzonieri","sequence":"additional","affiliation":[{"name":"Pathology Unit, CRO Aviano National Cancer Institute, Aviano, Italy;"},{"name":"Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4606-0637","authenticated-orcid":false,"given":"Luciano","family":"Cascione","sequence":"additional","affiliation":[{"name":"Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6371-097X","authenticated-orcid":false,"given":"Luca","family":"Ceriani","sequence":"additional","affiliation":[{"name":"Clinic of Nuclear Medicine and PET-CT Centre, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Cogliatti","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Kantonsspital St Gallen, St Gallen, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Corradini","sequence":"additional","affiliation":[{"name":"Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7154-8140","authenticated-orcid":false,"given":"Enrico","family":"Derenzini","sequence":"additional","affiliation":[{"name":"Onco-hematology Division, European Institute of Oncology (IEO) IRCCS, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1221-0326","authenticated-orcid":false,"given":"Liliana","family":"Devizzi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-1832","authenticated-orcid":false,"given":"Sascha","family":"Dietrich","sequence":"additional","affiliation":[{"name":"Division of Hematology, University Hospital Heidelberg, Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Rita","family":"Elia","sequence":"additional","affiliation":[{"name":"Cancer Immunotherapy, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Facchetti","sequence":"additional","affiliation":[{"name":"Department of Molecular and Translational Medicine, Pathology Unit, Spedali Civili, Brescia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-0151","authenticated-orcid":false,"given":"Gianluca","family":"Gaidano","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6974-0806","authenticated-orcid":false,"given":"Juan Fernando","family":"Garcia","sequence":"additional","affiliation":[{"name":"Division of Pathology, MD Anderson Cancer Center, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5418-0949","authenticated-orcid":false,"given":"Bernhard","family":"Gerber","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"},{"name":"Department of Hematology and Oncology, University of Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3750-7342","authenticated-orcid":false,"given":"Paolo","family":"Ghia","sequence":"additional","affiliation":[{"name":"Strategic Research Program on Chronic Lymphocytic Leukemia (CLL), IRCCS Ospedale San Raffaele and Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6993-2450","authenticated-orcid":false,"given":"Maria","family":"Gomes da Silva","sequence":"additional","affiliation":[{"name":"Division of Hematology, Instituto Portugu\u00eas de Oncologia de Lisboa, Lisbon, Portugal;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Gritti","sequence":"additional","affiliation":[{"name":"Division of Hematology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Guidetti","sequence":"additional","affiliation":[{"name":"Division of Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Hitz","sequence":"additional","affiliation":[{"name":"Division of Hematology, Kantonsspital St Gallen, St Gallen, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5566-0864","authenticated-orcid":false,"given":"Giorgio","family":"Inghirami","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Ladetto","sequence":"additional","affiliation":[{"name":"Division of Hematology, Azienda Ospedaliera SS Antonio e Biagio, Alessandria, Italy;"},{"name":"Dipartimento di Medicina Traslazionale, University of Eastern Piedmont, Alessandria, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Lopez-Guillermo","sequence":"additional","affiliation":[{"name":"Division of Lymphoid Neoplasms, Hospital Cl\u00ednic i Provincial de Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Lucchini","sequence":"additional","affiliation":[{"name":"Division of Hematology, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9634-2520","authenticated-orcid":false,"given":"Antonino","family":"Maiorana","sequence":"additional","affiliation":[{"name":"Division of Pathology, Universit\u00e1 degli Studi di Modena e Reggio Emilia, Modena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6431-6878","authenticated-orcid":false,"given":"Roberto","family":"Marasca","sequence":"additional","affiliation":[{"name":"Hematology Unit, Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, Modena, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estella","family":"Matutes","sequence":"additional","affiliation":[{"name":"Haematopathology Unit, Hospital Cl\u00ednic i Provincial de Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Meignin","sequence":"additional","affiliation":[{"name":"Division of Pathology, Saint Louis Hospital, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0905-5927","authenticated-orcid":false,"given":"Michele","family":"Merli","sequence":"additional","affiliation":[{"name":"Division of Hematology, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alden","family":"Moccia","sequence":"additional","affiliation":[{"name":"Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Mollejo","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC) 28029, Madrid, Spain;"},{"name":"Division of Pathology, Hospital Virgen de la Salud, Toledo, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Montalban","sequence":"additional","affiliation":[{"name":"Division of Hematology, MD Anderson Cancer Center, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urban","family":"Novak","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and University Cancer Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Graham","family":"Oscier","sequence":"additional","affiliation":[{"name":"Division of Hematology, University Hospitals Dorset, Bournemouth, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Passamonti","sequence":"additional","affiliation":[{"name":"Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2831-623X","authenticated-orcid":false,"given":"Francesco","family":"Piazza","sequence":"additional","affiliation":[{"name":"Division of Hematology, Ospedale Universitario di Padova, Padova, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Pizzolitto","sequence":"additional","affiliation":[{"name":"Division of Pathology, General Hospital S Maria della Misericordia, Udine, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sabattini","sequence":"additional","affiliation":[{"name":"Haematopathology Unit, Department of Experimental Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9541-8666","authenticated-orcid":false,"given":"Gilles","family":"Salles","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine et de Ma\u00efeutique Lyon Sud, Universit\u00e9 de Lyon, Lyon, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Santambrogio","sequence":"additional","affiliation":[{"name":"Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Turin, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"Scarf\u00f2","sequence":"additional","affiliation":[{"name":"Strategic Research Program on Chronic Lymphocytic Leukemia (CLL), IRCCS Ospedale San Raffaele and Universit\u00e0 Vita-Salute San Raffaele, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Stathis","sequence":"additional","affiliation":[{"name":"Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"St\u00fcssi","sequence":"additional","affiliation":[{"name":"Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"},{"name":"Faculty of Biomedical Sciences, Universit\u00e0 della Svizzera Italiana (USI), Lugano, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia T.","family":"Geyer","sequence":"additional","affiliation":[{"name":"Division of Anatomic Pathology and Clinical Pathology, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Tapia","sequence":"additional","affiliation":[{"name":"Division of Pathology, Hospital Germans Trias I Pujol, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrado","family":"Tarella","sequence":"additional","affiliation":[{"name":"Onco-hematology Division, European Institute of Oncology (IEO) IRCCS, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Thieblemont","sequence":"additional","affiliation":[{"name":"Assistance Publique\u2013H\u00f4pitaux de Paris, Hopital Saint-Louis, Hemato-Oncology Unit; Universit\u00e9 de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Tousseyn","sequence":"additional","affiliation":[{"name":"Department of Haematology, University Hospitals Leuven, Leuven, Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-7463","authenticated-orcid":false,"given":"Alessandra","family":"Tucci","sequence":"additional","affiliation":[{"name":"Division of Hematology, Spedali Civili, Brescia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Vanini","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and University Cancer Center, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Visco","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Hematology, University of Verona, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7772-2747","authenticated-orcid":false,"given":"Umberto","family":"Vitolo","sequence":"additional","affiliation":[{"name":"Candiolo Cancer Institute (FPO-IRCCS), Candiolo, Turin, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Walewska","sequence":"additional","affiliation":[{"name":"Division of Hematology, University Hospitals Dorset, Bournemouth, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Zaja","sequence":"additional","affiliation":[{"name":"Division of Hematology, Azienda Sanitaria Universitaria Giuliano Isontina, Trieste, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2112-2651","authenticated-orcid":false,"given":"Pier Luigi","family":"Zinzani","sequence":"additional","affiliation":[{"name":"IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Ser\u00e0gnoli, Bologna, Italy;"},{"name":"Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Universit\u00e0 di Bologna, Bologna, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1446-4394","authenticated-orcid":false,"given":"Hossein","family":"Khiabanian","sequence":"additional","affiliation":[{"name":"Center for Systems and Computational Biology, Rutgers University, New Brunswick, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1746-6424","authenticated-orcid":false,"given":"Arianna","family":"Calcinotto","sequence":"additional","affiliation":[{"name":"Cancer Immunotherapy, Institute of Oncology Research, Bellinzona, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bertoni","sequence":"additional","affiliation":[{"name":"Lymphoma Genomics, Institute of Oncology Research, Bellinzona, Switzerland;"},{"name":"Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"},{"name":"Faculty of Biomedical Sciences, Universit\u00e0 della Svizzera Italiana (USI), Lugano, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6250-048X","authenticated-orcid":false,"given":"Govind","family":"Bhagat","sequence":"additional","affiliation":[{"name":"Department of Pathology and Cell Biology, Columbia University, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9850-9793","authenticated-orcid":false,"given":"Elias","family":"Campo","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigacions Biom\u00e8diques August Pi Sunyer (IDIBAPS),"},{"name":"Pathology Department, Hospital Cl\u00ednic, Barcelona University, Barcelona, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"De Leval","sequence":"additional","affiliation":[{"name":"Division of Pathology, Institut Universitaire de Pathologie, Lausanne, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Dirnhofer","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano A.","family":"Pileri","sequence":"additional","affiliation":[{"name":"Haematopathology Division, European Institute of Oncology IRCCS, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer (CIBERONC) 28029, Madrid, Spain;"},{"name":"Pathology Service, Fundaci\u00f3n Jim\u00e9nez D\u00edaz, Madrid, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Traverse-Glehen","sequence":"additional","affiliation":[{"name":"Division of Pathology, Centre Hospitalier Lyon Sud, Lyon, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1100-3819","authenticated-orcid":false,"given":"Alexander","family":"Tzankov","sequence":"additional","affiliation":[{"name":"Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paulli","sequence":"additional","affiliation":[{"name":"Unit of Anatomic Pathology, Department of Molecular Medicine, Fondazione IRCCS Policlinico San Matteo and Universit\u00e0 degli Studi di Pavia, Pavia, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurilio","family":"Ponzoni","sequence":"additional","affiliation":[{"name":"Ateneo Vita-Salute San Raffaele University and Pathology Unit San Raffaele Scientific Institute, Milan, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Mazzucchelli","sequence":"additional","affiliation":[{"name":"Division of Pathology, Cantonal Institute of Pathology, Locarno, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Cavalli","sequence":"additional","affiliation":[{"name":"Institute of Oncology Research, Bellinzona, Switzerland; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5522-6109","authenticated-orcid":false,"given":"Emanuele","family":"Zucca","sequence":"additional","affiliation":[{"name":"International Extranodal Lymphoma Study Group, Bellinzona, Switzerland;"},{"name":"Clinic of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"},{"name":"Faculty of Biomedical Sciences, Universit\u00e0 della Svizzera Italiana (USI), Lugano, Switzerland;"},{"name":"Department of Medical Oncology, Bern University Hospital and University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Rossi","sequence":"additional","affiliation":[{"name":"Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland;"},{"name":"Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;"},{"name":"Faculty of Biomedical Sciences, Universit\u00e0 della Svizzera Italiana (USI), Lugano, Switzerland;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6","key":"2022030320314588300_B1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/bjh.16489","article-title":"Trends in the prevalence, incidence and survival of non-Hodgkin lymphoma subtypes during the 21st century - a Swedish lymphoma register study","volume":"189","author":"Ekberg","year":"2020","journal-title":"Br J Haematol."},{"issue":"9","key":"2022030320314588300_B2","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1038\/bjc.2015.94","article-title":"Lymphoma incidence, survival and prevalence 2004-2014: sub-type analyses from the UK\u2019s Haematological Malignancy Research Network","volume":"112","author":"Smith","year":"2015","journal-title":"Br J Cancer."},{"issue":"21","key":"2022030320314588300_B3","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1002\/cncr.33117","article-title":"Splenic marginal zone lymphoma: a US population-based survival analysis (1999-2016)","volume":"126","author":"Florindez","year":"2020","journal-title":"Cancer."},{"issue":"10","key":"2022030320314588300_B4","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1182\/blood.2019001088","article-title":"Early progression as a predictor of survival in marginal zone lymphomas: an analysis from the FIL-NF10 study","volume":"134","author":"Luminari","year":"2019","journal-title":"Blood."},{"issue":"9","key":"2022030320314588300_B5","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1084\/jem.20120910","article-title":"Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma","volume":"209","author":"Kiel","year":"2012","journal-title":"J Exp Med."},{"issue":"9","key":"2022030320314588300_B6","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1084\/jem.20120904","article-title":"The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development","volume":"209","author":"Rossi","year":"2012","journal-title":"J Exp Med."},{"issue":"18","key":"2022030320314588300_B7","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1158\/1078-0432.CCR-14-2759","article-title":"Genetics and prognostication in splenic marginal zone lymphoma: revelations from deep sequencing","volume":"21","author":"Parry","year":"2015","journal-title":"Clin Cancer Res."},{"issue":"5","key":"2022030320314588300_B8","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/leu.2014.330","article-title":"KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype","volume":"29","author":"Clipson","year":"2014","journal-title":"Leukemia."},{"issue":"2","key":"2022030320314588300_B9","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/leu.2014.294","article-title":"The Kr\u00fcppel-like factor 2 transcription factor gene is recurrently mutated in splenic marginal zone lymphoma","volume":"29","author":"Piva","year":"2014","journal-title":"Leukemia."},{"issue":"18","key":"2022030320314588300_B10","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2011-06-359166","article-title":"Alteration of BIRC3 and multiple other NF-\u03baB pathway genes in splenic marginal zone lymphoma","volume":"118","author":"Rossi","year":"2011","journal-title":"Blood."},{"issue":"20","key":"2022030320314588300_B11","doi-asserted-by":"crossref","first-page":"4918","DOI":"10.1182\/blood-2008-08-174110","article-title":"The NF-kappaB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas","volume":"113","author":"Novak","year":"2009","journal-title":"Blood."},{"issue":"1","key":"2022030320314588300_B12","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.humpath.2005.09.016","article-title":"CD14 and CD169 expression in human lymph nodes and spleen: specific expansion of CD14+CD169- monocyte-derived cells in diffuse large B-cell lymphomas","volume":"37","author":"Marmey","year":"2006","journal-title":"Hum Pathol."},{"issue":"22","key":"2022030320314588300_B13","doi-asserted-by":"crossref","first-page":"5773","DOI":"10.1182\/bloodadvances.2020003121","article-title":"Durable ibrutinib responses in relapsed\/refractory marginal zone lymphoma: long-term follow-up and biomarker analysis","volume":"4","author":"Noy","year":"2020","journal-title":"Blood Adv."},{"key":"2022030320314588300_B14","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2020.258426","article-title":"A deep molecular response of splenic marginal zone lymphoma to front-line checkpoint blockade","volume-title":"Haematologica.","author":"Miller"},{"issue":"15","key":"2022030320314588300_B15","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1200\/JCO.20.03433","article-title":"Umbralisib, a dual PI3K\u03b4\/CK1\u03b5 inhibitor in patients with relapsed or refractory indolent lymphoma","volume":"39","author":"Fowler","year":"2021","journal-title":"J Clin Oncol."},{"key":"2022030320314588300_B16","first-page":"223","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Piris","year":"2017","edition":"4th ed"},{"issue":"8-9","key":"2022030320314588300_B17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.exger.2005.06.011","article-title":"Tissue microarray technology: principles, pitfalls and perspectives--lessons learned from hematological malignancies","volume":"40","author":"Tzankov","year":"2005","journal-title":"Exp Gerontol."},{"issue":"5","key":"2022030320314588300_B18","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0002-9440(10)65411-9","article-title":"7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma","volume":"154","author":"Mateo","year":"1999","journal-title":"Am J Pathol."},{"issue":"4","key":"2022030320314588300_B19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/path.5209","article-title":"Disease-biased and shared characteristics of the immunoglobulin gene repertoires in marginal zone B cell lymphoproliferations","volume":"247","author":"Xochelli","year":"2019","journal-title":"J Pathol."},{"issue":"12","key":"2022030320314588300_B20","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1182\/blood-2005-11-4659","article-title":"Splenic marginal zone lymphoma: a prognostic model for clinical use","volume":"107","author":"Arcaini","year":"2006","journal-title":"Blood."},{"issue":"2","key":"2022030320314588300_B21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/bjh.12011","article-title":"Risk stratification for Splenic Marginal Zone Lymphoma based on haemoglobin concentration, platelet count, high lactate dehydrogenase level and extrahilar lymphadenopathy: development and validation on 593 cases","volume":"159","author":"Montalb\u00e1n","year":"2012","journal-title":"Br J Haematol."},{"issue":"1","key":"2022030320314588300_B22","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1038\/s41598-019-46906-1","article-title":"Systematic review of somatic mutations in splenic marginal zone lymphoma","volume":"9","author":"Jaramillo Oquendo","year":"2019","journal-title":"Sci Rep."},{"issue":"15","key":"2022030320314588300_B23","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N Engl J Med."},{"issue":"7574","key":"2022030320314588300_B24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature."},{"issue":"23","key":"2022030320314588300_B25","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv."},{"issue":"26","key":"2022030320314588300_B26","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1182\/blood.2019002067","article-title":"Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade","volume":"134","author":"Chapuy","year":"2019","journal-title":"Blood."},{"issue":"2","key":"2022030320314588300_B27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ng.2856","article-title":"Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma","volume":"46","author":"Okosun","year":"2013","journal-title":"Nat Genet."},{"issue":"2","key":"2022030320314588300_B28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nri3383","article-title":"Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes","volume":"13","author":"Cerutti","year":"2013","journal-title":"Nat Rev Immunol."},{"issue":"11","key":"2022030320314588300_B29","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.3390\/ijms18112383","article-title":"KLF2 in regulation of NF-\u03baB-mediated immune cell function and inflammation","volume":"18","author":"Jha","year":"2017","journal-title":"Int J Mol Sci."},{"issue":"12","key":"2022030320314588300_B30","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1073\/pnas.0800218105","article-title":"Inositol trisphosphate 3-kinase B (InsP3KB) as a physiological modulator of myelopoiesis","volume":"105","author":"Jia","year":"2008","journal-title":"Proc Natl Acad Sci USA."},{"issue":"2","key":"2022030320314588300_B31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/ng.3473","article-title":"Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma","volume":"48","author":"Okosun","year":"2015","journal-title":"Nat Genet."},{"issue":"1","key":"2022030320314588300_B32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics."},{"issue":"1","key":"2022030320314588300_B33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13073-016-0280-5","article-title":"A roadmap of constitutive NF-\u03baB activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses","volume":"8","author":"de Oliveira","year":"2016","journal-title":"Genome Med."},{"key":"2022030320314588300_B34","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-20-0839","article-title":"Clinical and biological subtypes of B-cell lymphoma revealed by microenvironmental signatures","volume-title":"Cancer Discov.","author":"Kotlov"},{"issue":"2","key":"2022030320314588300_B35","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1182\/blood.V95.2.627","article-title":"The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia","volume":"95","author":"Jones","year":"2000","journal-title":"Blood."},{"issue":"10","key":"2022030320314588300_B36","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/ijc.25236","article-title":"Perivascular expression of CXCL9 and CXCL12 in primary central nervous system lymphoma: T-cell infiltration and positioning of malignant B cells","volume":"127","author":"Venetz","year":"2010","journal-title":"Int J Cancer."},{"issue":"3","key":"2022030320314588300_B37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00277-013-1878-y","article-title":"IP-10\/CXCL10 and MIG\/CXCL9 as novel markers for the diagnosis of lymphoma-associated hemophagocytic syndrome","volume":"93","author":"Maruoka","year":"2013","journal-title":"Ann Hematol."},{"issue":"13","key":"2022030320314588300_B38","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1182\/blood-2008-06-162404","article-title":"CX3CL1\/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis","volume":"112","author":"Truman","year":"2008","journal-title":"Blood."},{"issue":"3","key":"2022030320314588300_B39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PPO.0000000000000446","article-title":"Role of microenvironment in non-Hodgkin lymphoma: understanding the composition and biology","volume":"26","author":"Khurana","year":"2020","journal-title":"Cancer J."},{"issue":"7","key":"2022030320314588300_B40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/modpathol.2012.220","article-title":"Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling","volume":"26","author":"Arribas","year":"2013","journal-title":"Mod Pathol."},{"issue":"7","key":"2022030320314588300_B41","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol."},{"issue":"10","key":"2022030320314588300_B42","doi-asserted-by":"crossref","first-page":"E1116","DOI":"10.1073\/pnas.1501199112","article-title":"Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation","volume":"112","author":"Green","year":"2015","journal-title":"Proc Natl Acad Sci USA."},{"issue":"6","key":"2022030320314588300_B43","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell."},{"issue":"4","key":"2022030320314588300_B44","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41591-020-0757-z","article-title":"TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma","volume":"26","author":"Ennishi","year":"2020","journal-title":"Nat Med."},{"issue":"4","key":"2022030320314588300_B45","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov."},{"issue":"3","key":"2022030320314588300_B46","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/2159-8290.CD-19-0116","article-title":"Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma","volume":"10","author":"Mondello","year":"2020","journal-title":"Cancer Discov."},{"issue":"2","key":"2022030320314588300_B47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cell.2016.08.032","article-title":"Loss of the HVEM tumor suppressor in lymphoma and restoration by modified CAR-T cells","volume":"167","author":"Boice","year":"2016","journal-title":"Cell."},{"issue":"1","key":"2022030320314588300_B48","first-page":"3","article-title":"Splenic marginal zone B-cell and thymic T-cell lymphomas in p53-deficient mice","volume":"79","author":"Ward","year":"1999","journal-title":"Lab Invest."},{"issue":"8","key":"2022030320314588300_B49","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1073\/pnas.1222570110","article-title":"Conditional inactivation of p53 in mature B cells promotes generation of nongerminal center-derived B-cell lymphomas","volume":"110","author":"Gostissa","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"2022030320314588300_B50","article-title":"NCCN Guidelines. Version 4. 2019. B-cell lymphomas: splenic marginal zone lymphoma","author":"National Comprehensive Cancer Network (NCCN)"},{"issue":"1","key":"2022030320314588300_B51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.annonc.2019.10.010","article-title":"Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Zucca","year":"2020","journal-title":"Ann Oncol."},{"issue":"5","key":"2022030320314588300_B52","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1182\/blood-2004-07-2947","article-title":"Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response","volume":"105","author":"Monti","year":"2005","journal-title":"Blood."},{"issue":"5","key":"2022030320314588300_B53","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med."},{"issue":"5","key":"2022030320314588300_B54","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Rinaldi","year":"2011","journal-title":"Blood."},{"issue":"6","key":"2022030320314588300_B55","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/sj.leu.2405027","article-title":"The prevalence of IG translocations and 7q32 deletions in splenic marginal zone lymphoma","volume":"22","author":"Remstein","year":"2007","journal-title":"Leukemia."},{"issue":"9","key":"2022030320314588300_B56","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood."},{"issue":"3","key":"2022030320314588300_B57","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/sj.leu.2405068","article-title":"Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria","volume":"22","author":"Matutes","year":"2007","journal-title":"Leukemia."},{"key":"2022030320314588300_B58","doi-asserted-by":"crossref","DOI":"10.1038\/nm.4466","article-title":"High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy","author":"Krieg","year":"2018"},{"issue":"9","key":"2022030320314588300_B59","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/s41591-020-1006-1","article-title":"A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma","volume":"26","author":"Cader","year":"2020","journal-title":"Nat Med."}],"updated-by":[{"DOI":"10.1182\/blood.2023019847","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T00:00:00Z","timestamp":1680134400000}}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/5\/732\/1874461\/bloodbld2021012386.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/139\/5\/732\/1874461\/bloodbld2021012386.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T20:32:25Z","timestamp":1646339545000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/139\/5\/732\/477330\/Genetic-and-phenotypic-attributes-of-splenic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":59,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,2,3]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021012386","relation":{"erratum":[{"id-type":"doi","id":"10.1182\/blood.2023019847","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]}}}